Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
Video
New Euro hypertension guidelines target most adults to less than 130/80 mm Hg
- Author:
- Mitchel L. Zoler, PhD
MUNICH – Revised European hypertension guidelines endorse a less than 130/80 mm Hg target but with more...
News
Pregnancy boosts cardiac disease mortality nearly 100-fold
- Author:
- Mitchel L. Zoler, PhD
MUNICH – Registry data from more than 5,700 women with cardiac disease who became pregnant provide insight on complication rates.
News
Coronary CT angiography radiation dose fell 78% from 2007-2017
- Author:
- Mitchel L. Zoler, PhD
MUNICH – A 2017 survey of coronary CT angiography radiation doses for 4,502 patients at 61 worldwide sites...
News
New MI definition aims to better distinguish infarction from injury
- Author:
- Mitchel L. Zoler, PhD
MUNICH – By endorsing high sensitivity cardiac troponin and cardiac MR as diagnostic cornerstones, the new MI definition stands to change U.S....
News
FOURIER analysis: PCSK9 inhibition helps MetS patients the most
- Author:
- Mitchel L. Zoler, PhD
MUNICH – Evolocumab showed the most benefit in patients with metabolic syndrome in a post hoc analysis of the...
News
Neural-tube defect signal from dolutegravir HIV treatment raises concerns
- Author:
- Mitchel L. Zoler, PhD
AMSTERDAM – A safety signal linking neonatal neural-tube defects to HIV+ mothers treated with dolutegravir...
News
U.S. HIV clinical care fails the hardest hit
- Author:
- Mitchel L. Zoler, PhD
AMSTERDAM – The biggest, fastest-growing U.S. groups getting HIV are minorities, young adults, and MSM – people...
News
Dolutegravir plus 3TC matches three drugs for HIV control
- Author:
- Mitchel L. Zoler, PhD
Results from a pair of phase 3 trials showed two drugs – dolutegravir and lamivudine – worked as well as three...
News
On-demand and daily PrEP look similar for HIV prevention
- Author:
- Mitchel L. Zoler, PhD
Prospective study of more than 1,100 French MSM showed on-demand PrEP performed as well as daily PrEP for preventing HIV infection.
News
Rising U.S. PrEP use linked with dropping HIV infections
- Author:
- Mitchel L. Zoler, PhD
As use of preexposure prophylaxis against HIV spread since its 2012 FDA approval, HIV infection rates have...
News
‘Undetectable’ HIV means ‘untransmissible’ confirmed in larger sex study
- Author:
- Mitchel L. Zoler, PhD
AMSTERDAM – A prospective study of nearly 77,000 unprotected anal sex episodes among men confirmed that...
News
People with HIV develop more frailty despite treatment
- Author:
- Mitchel L. Zoler, PhD
AMSTERDAM – Middle-aged and elderly people with HIV developed more frailty than did similar uninfected people, and frailty predicted worse...
Video
Incident heart failure linked to HIV infection
- Author:
- Mitchel L. Zoler, PhD
AMSTERDAM – Medical records from a large U.S. health system suggest that incident heart failure independently links to HIV infection.
Video
Novel HIV vaccine induces durable immune responses
- Author:
- Mitchel L. Zoler, PhD
AMSTERDAM – Follow-up of HIV-vaccine recipients 1 year after their final dose in a phase I/IIa trial showed continued safety and anti-HIV...
News
HIV infection linked with doubled stroke rate
- Author:
- Mitchel L. Zoler, PhD
AMSTERDAM – Data from more than 22 million Taiwan residents showed HIV-infected patients had a doubled stroke rate compared with the general...